The Role of GDF-15 in Heart Failure Patients With Chronic Kidney Disease

被引:31
作者
Benes, Jan [1 ]
Kotrc, Martin [1 ]
Wohlfahrt, Peter [1 ,2 ,3 ]
Conrad, Michael J. [4 ]
Franekova, Janka [5 ,6 ]
Jabor, Antonin [5 ,6 ]
Lupinek, Petr [1 ]
Kautzner, Josef [1 ]
Melenovsky, Vojtech [1 ]
Jarolim, Petr [4 ]
机构
[1] Inst Clin & Expt Med IKEM, Dept Cardiol, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Ctr Cardiovasc Prevent, Prague, Czech Republic
[3] Thomayer Hosp, Prague, Czech Republic
[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[5] Inst Clin & Expt Med IKEM, Dept Lab Methods, Prague, Czech Republic
[6] Charles Univ Prague, Fac Med 3, Prague, Czech Republic
关键词
GROWTH-DIFFERENTIATION FACTOR-15; NATRIURETIC PEPTIDE; INHIBITORY CYTOKINE-1; RENAL-FUNCTION; POPULATION; VALIDATION; MARKER;
D O I
10.1016/j.cjca.2018.12.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Growth differentiation factor-15 (GDF-15) is a stressinducible cytokine and member of the transforming growth factor-b cytokine superfamily that refines prognostic assessment in subgroups of patients with heart failure (HF). We evaluated its role in HF patients with chronic kidney disease (CKD, estimated glomerular filtration rate < 60 mL/min/1.73 m(2)). Methods: A total of 358 patients with stable systolic HF were followed for a median of 1121 (interquartile range, 379-2600) days. Comprehensive evaluation including B-type natriuretic peptide (BNP) and GDF15 testing was performed at study entry; the analysis was stratified according to kidney function. Results: Patients with CKD (33.8%) were older, had more often diabetes, and were less often treated with angiotensin converting enzyme inhibitors (ACEi)/angiotensin receptor blockers (ARB). GDF-15 was associated with estimated glomerular filtration rate, whereas BNP was associated with left ventricular-end diastolic diameter and ejection fraction (P < 0.01). During follow-up, 244 patients (68.2%) experienced an adverse outcome 9death, urgent transplantation, implantation of mechanical circulatory support). In patients with HF and CKD, the Cox proportional hazard model identified BNP, GDF-15, sex, systolic blood pressure, sodium, total cholesterol, and ACEi/ARB treatment as significant variables associated with an adverse outcome 9P < 0.05). In multivariable analysis, BNP was replaced by GDF-15. Net reclassification improvement confirmed prognostic superiority of the model encompassing GDF-15 9GDF-15, sodium, total cholesterol, ACEi/ARB treatment) compared with the model without GDF-15 9BNP, sex, sodium, ACEi/ARB treatment), net reclassification improvement 0.62, P = 0.005. In contrast, in patients with HF and normal kidney function, BNP remained superior to GDF-15 in a multivariable model. Conclusions: In patients with systolic HF and CKD, GDF-15 is more strongly associated with adverse outcomes than the conventionally used BNP.
引用
收藏
页码:462 / 470
页数:9
相关论文
共 32 条
[1]   Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation [J].
Aaronson, KD ;
Schwartz, JS ;
Chen, TM ;
Wong, KL ;
Goin, JE ;
Mancini, DM .
CIRCULATION, 1997, 95 (12) :2660-2667
[2]   Serial Measurement of Growth-Differentiation Factor-15 in Heart Failure Relation to Disease Severity and Prognosis in the Valsartan Heart Failure Trial [J].
Anand, Inder S. ;
Kempf, Tibor ;
Rector, Thomas S. ;
Tapken, Heike ;
Allhoff, Tim ;
Jantzen, Franziska ;
Kuskowski, Michael ;
Cohn, Jay N. ;
Drexler, Helmut ;
Wollert, Kai C. .
CIRCULATION, 2010, 122 (14) :1387-+
[3]   Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery [J].
Bermudez, Beatriz ;
Lopez, Sergio ;
Pacheco, Yolanda M. ;
Villar, Jose ;
Muriana, Francisco J. G. ;
Hoheisel, Joeerg D. ;
Bauer, Andrea ;
Abia, Rocio .
CARDIOVASCULAR RESEARCH, 2008, 79 (02) :294-303
[4]   Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction [J].
Chan, Michelle M. Y. ;
Santhanakrishnan, Rajalakshmi ;
Chong, Jenny P. C. ;
Chen, Zhaojin ;
Tai, Bee Choo ;
Liew, Oi Wah ;
Ng, Tze Pin ;
Ling, Lieng H. ;
Sim, David ;
Leong, Toh G. ;
Yeo, Poh Shuan Daniel ;
Ong, Hean-Yee ;
Jaufeerally, Fazlur ;
Wong, Raymond Ching-Chiew ;
Chai, Ping ;
Low, Adrian F. ;
Richards, Arthur M. ;
Lam, Carolyn S. P. .
EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (01) :81-88
[5]   Concise Review: Growth Differentiation Factor 15 in Pathology: A Clinical Role? [J].
Corre, Jill ;
Hebraud, Benjamin ;
Bourin, Philippe .
STEM CELLS TRANSLATIONAL MEDICINE, 2013, 2 (12) :946-952
[6]   Natriureettic peptides [J].
Daniels, Lori B. ;
Maisel, Alan S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (25) :2357-2368
[7]   B-Type Natriuretic Peptide (BNP)/NT-proBNP and Renal Function: Is the Controversy Over? [J].
deFilippi, Christopher R. ;
Christenson, Robert H. .
CLINICAL CHEMISTRY, 2009, 55 (07) :1271-1273
[8]   COMPARING THE AREAS UNDER 2 OR MORE CORRELATED RECEIVER OPERATING CHARACTERISTIC CURVES - A NONPARAMETRIC APPROACH [J].
DELONG, ER ;
DELONG, DM ;
CLARKEPEARSON, DI .
BIOMETRICS, 1988, 44 (03) :837-845
[9]   Chronic kidney disease and cardiovascular complications [J].
Di Lullo, Luca ;
House, Andrew ;
Gorini, Antonio ;
Santoboni, Alberto ;
Russo, Domenico ;
Ronco, Claudio .
HEART FAILURE REVIEWS, 2015, 20 (03) :259-272
[10]   Identification of Macrophage Inhibitory Cytokine-1 in Adipose Tissue and Its Secretion as an Adipokine by Human Adipocytes [J].
Ding, Qi ;
Mracek, Tomas ;
Gonzalez-Muniesa, Pedro ;
Kos, Katarina ;
Wilding, John ;
Trayhurn, Paul ;
Bing, Chen .
ENDOCRINOLOGY, 2009, 150 (04) :1688-1696